322 related articles for article (PubMed ID: 25572531)
1. Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors.
Di Miceli M; Gronier B
Psychopharmacology (Berl); 2015 Jun; 232(12):2191-205. PubMed ID: 25572531
[TBL] [Abstract][Full Text] [Related]
2. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors.
Gronier B
Eur Neuropsychopharmacol; 2011 Feb; 21(2):192-204. PubMed ID: 21146374
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.
Gamo NJ; Wang M; Arnsten AF
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1011-23. PubMed ID: 20855046
[TBL] [Abstract][Full Text] [Related]
4. Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex.
Chen L; Yang CR
J Neurophysiol; 2002 May; 87(5):2324-36. PubMed ID: 11976371
[TBL] [Abstract][Full Text] [Related]
5. The dopaminergic stabilizer pridopidine increases neuronal activity of pyramidal neurons in the prefrontal cortex.
Gronier B; Waters S; Ponten H
J Neural Transm (Vienna); 2013 Sep; 120(9):1281-94. PubMed ID: 23468085
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors.
Cheng J; Xiong Z; Duffney LJ; Wei J; Liu A; Liu S; Chen GJ; Yan Z
Biol Psychiatry; 2014 Dec; 76(12):953-62. PubMed ID: 24832867
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms.
Tseng KY; O'Donnell P
J Neurosci; 2004 Jun; 24(22):5131-9. PubMed ID: 15175382
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine promotes cortical Up state: Role of adrenergic receptors.
Shen G; Shi WX
Addict Biol; 2021 Jan; 26(1):e12879. PubMed ID: 32003119
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
Sarantis K; Matsokis N; Angelatou F
Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate amplifies long-term potentiation in rat hippocampus CA1 area involving the insertion of AMPA receptors by activation of β-adrenergic and D1/D5 receptors.
Rozas C; Carvallo C; Contreras D; Carreño M; Ugarte G; Delgado R; Zeise ML; Morales B
Neuropharmacology; 2015 Dec; 99():15-27. PubMed ID: 26165920
[TBL] [Abstract][Full Text] [Related]
11. Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex.
Lecourtier L; Homayoun H; Tamagnan G; Moghaddam B
Biol Psychiatry; 2007 Oct; 62(7):739-46. PubMed ID: 17511968
[TBL] [Abstract][Full Text] [Related]
12. Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine.
Shi WX; Zhang XX
J Pharmacol Exp Ther; 2003 May; 305(2):680-7. PubMed ID: 12606677
[TBL] [Abstract][Full Text] [Related]
13. cAMP and extracellular signal-regulated kinase signaling in response to d-amphetamine and methylphenidate in the prefrontal cortex in vivo: role of beta 1-adrenoceptors.
Pascoli V; Valjent E; Corbillé AG; Corvol JC; Tassin JP; Girault JA; Hervé D
Mol Pharmacol; 2005 Aug; 68(2):421-9. PubMed ID: 15890841
[TBL] [Abstract][Full Text] [Related]
14. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action.
Zhang CL; Feng ZJ; Liu Y; Ji XH; Peng JY; Zhang XH; Zhen XC; Li BM
PLoS One; 2012; 7(12):e51910. PubMed ID: 23284812
[TBL] [Abstract][Full Text] [Related]
16. Disrupted Glutamatergic Transmission in Prefrontal Cortex Contributes to Behavioral Abnormality in an Animal Model of ADHD.
Cheng J; Liu A; Shi MY; Yan Z
Neuropsychopharmacology; 2017 Sep; 42(10):2096-2104. PubMed ID: 28176786
[TBL] [Abstract][Full Text] [Related]
17. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
Arvanov VL; Wang RY
Neuropsychopharmacology; 1998 Mar; 18(3):197-209. PubMed ID: 9471117
[TBL] [Abstract][Full Text] [Related]
18. Methylphenidate significantly alters the functional coupling between the prefrontal cortex and dopamine neurons in the ventral tegmental area.
Dela Peña IC; Shen G; Shi WX
Neuropharmacology; 2018 Mar; 131():431-439. PubMed ID: 29339293
[TBL] [Abstract][Full Text] [Related]
19. Treatment with a clinically-relevant dose of methylphenidate alters NMDA receptor composition and synaptic plasticity in the juvenile rat prefrontal cortex.
Urban KR; Li YC; Gao WJ
Neurobiol Learn Mem; 2013 Mar; 101():65-74. PubMed ID: 23333502
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.
Bradshaw SE; Agster KL; Waterhouse BD; McGaughy JA
Brain Res; 2016 Jun; 1641(Pt B):245-57. PubMed ID: 26774596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
